文献速递免疫规划传染病防控与疫情报告

单价轮状病毒疫苗在塔吉克斯坦儿童中的影响与效果

Impact and effectiveness of monovalent rotavirus vaccine in Tajik children.
PubMed 文献 · Vaccine · 2022-05-14

塔吉克斯坦2015年将轮状病毒疫苗纳入国家免疫规划。研究利用2013至2019年监测数据,分析5岁以下儿童住院趋势,并用检测阴性病例对照设计估计2017至2019年疫苗效果。结果显示疫苗引入后轮状病毒阳性率由42%降至25%,下降41%(95%CI:36-45%);完整接种程序疫苗效果在5-59月龄儿童为55%(95%CI:21-73%),在5-23月龄儿童为64%(95%CI:36-80%)。

要点

  • 疫苗引入后轮状病毒阳性率由42%降至25%,下降41%(95%CI:36-45%)
  • 12月龄以下儿童下降幅度最大
  • 完整接种程序疫苗效果5-59月龄为55%(95%CI:21-73%),5-23月龄为64%(95%CI:36-80%)

核心结论

  • 数据表明轮状病毒疫苗引入与塔吉克斯坦儿童轮状病毒住院负担大幅下降相关,且轮状病毒疫苗接种在塔吉克儿童中有效。

研究设计与样本

  • 利用2013至2019年监测数据,分析疫苗引入前后5岁以下儿童每月住院入院趋势,采用泊松回归量化下降幅度。
  • 采用检测阴性病例对照设计,使用2017至2019年入院数据估计疫苗效果,免疫接种记录来自诊所。

主要发现

  • 纳入儿童中,轮状病毒阳性率由疫苗引入前的42%降至引入后的25%,下降41%(95%CI:36-45%)。
  • 下降幅度在12月龄以下儿童中最大。
  • 完整接种程序轮状病毒疫苗效果在5-59月龄儿童为55%(95%CI:21-73%),在5-23月龄儿童为64%(95%CI:36-80%)。
  • 与口服脊髓灰质炎疫苗非同时接种两剂轮状病毒疫苗的儿童、以及4-11月龄接种首剂轮状病毒疫苗的儿童,疫苗效果点估计较高,但置信区间宽且重叠。

关键数值与推荐

  • 完整接种程序轮状病毒疫苗效果:5-59月龄儿童55%(95%CI:21-73%)。
  • 完整接种程序轮状病毒疫苗效果:5-23月龄儿童64%(95%CI:36-80%)。
  • 疫苗引入后轮状病毒阳性率由42%降至25%,下降41%(95%CI:36-45%)。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 与口服脊髓灰质炎疫苗非同时接种两剂轮状病毒疫苗的儿童、以及4-11月龄接种首剂轮状病毒疫苗的儿童,疫苗效果点估计较高,但置信区间宽且重叠。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2015, Tajikistan became the second country in Central Asia to introduce rotavirus vaccine into its national immunization program. Before vaccine introduction, rotavirus was estimated to cause > 40% of pediatric diarrhea hospitalizations in Tajikistan. We aimed to assess the impact of rotavirus vaccine introduction on rotavirus disease burden and estimate rotavirus vaccine effectiveness (VE). METHODS: Using surveillance data from 2013 through 2019, we examined trends in monthly hospital admissions among children < 5 years old, before and after rotavirus vaccine introduction. Poisson regression was used to quantify decreases. VE was estimated using a test-negative case control design, with data from admissions during 2017 - 2019. Immunization records were obtained from clinics. RESULTS: Among enrolled children, rotavirus positivity declined from 42% to 25% in the post-vaccine introduction period, a decrease of 41% (95% Confidence Interval [CI]: 36 - 45%). Declines were greatest in children < 12 months of age. Estimated VE of a complete course of rotavirus vaccine was 55% (95% CI: 21 - 73%) among children 5 - 59 months of age and 64% (95% CI: 36 - 80%) among children 5 - 23 months of age. VE point estimates were higher among children receiving both doses of rotavirus vaccine non-concurrently with OPV and among children receiving their first dose of rotavirus vaccine at 4 - 11 months of age, but CIs were wide and overlapping. CONCLUSIONS: Our data demonstrate that rotavirus vaccine introduction was associated with a substantial reduction in pediatric rotavirus hospitalization burden in Tajikistan, and that rotavirus vaccination is effective in Tajik children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nazurdinov A, Azizov Z, Mullojonova M, et al. Impact and effectiveness of monovalent rotavirus vaccine in Tajik children. Vaccine. 2022. PMID: 35581101. doi:10.1016/j.vaccine.2022.05.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。